Abstract
As all major dietary carotenoids are contained in blood, it is a suitable substrate to evaluate their content, in vivo. Following 18-month supplementation of open-angle glaucoma patients with macula-pigment carotenoids (Lutein, Zeaxanthin and Meso-Zeaxanthin) in the European Nutrition in Glaucoma Management trial, Raman spectroscopic analysis of the carotenoid content of pre- and post-supplementation participant blood serum was carried out, to investigate the systemic impact of the supplementation regimen and explore a more direct way of quantifying this impact using routine blood tests. Using a 532 nm laser source for optimal response, a consistent increase in serum carotenoid concentration was observed in the supplemented serum, highest in patients with initial high baseline carotenoid content. A shift in the 1519 cm−1 carotenoid peak also revealed differences in the carotenoid structural profile of the two groups. The findings highlight the potential of Raman spectroscopy toquantify and differentiate carotenoids directly in blood serum.
| Original language | English |
|---|---|
| Article number | e202400060 |
| Journal | Journal of Biophotonics |
| Volume | 17 |
| Issue number | 8 |
| DOIs | |
| Publication status | Published - Aug 2024 |
Keywords
- Blood serum
- Carotenoids
- Glaucoma
- Macular carotenoids
- Macular pigment
- Raman-spectroscopy